RM, E., HL, G., & RA, M. (2013). Ruxolitinib as an emerging treatment in myelofibrosis. Dove Medical Press.
Cita Chicago Style (17a ed.)RM, Emanuel, Geyer HL, y Mesa RA. Ruxolitinib as an Emerging Treatment in Myelofibrosis. Dove Medical Press, 2013.
Cita MLA (8a ed.)RM, Emanuel, et al. Ruxolitinib as an Emerging Treatment in Myelofibrosis. Dove Medical Press, 2013.
Precaución: Estas citas no son 100% exactas.